AI-Driven Platform for Protein Design, Optimization, and Computational Engineering

AI-Driven Protein Engineering Platform

Modern protein engineering requires navigating vast protein sequence spaces while balancing multiple performance objectives, including stability, activity, manufacturability, affinity, and expression.

Neoncorte Bio's Protein Engineering Platform combines artificial intelligence, machine learning, computational biology, and protein language models to help research teams prioritize promising protein variants and accelerate Design-Build-Test-Learn (DBTL) workflows.

The platform supports enzyme engineering, antibody optimization, therapeutic protein development, synthetic biology, and industrial biotechnology projects through AI-assisted computational analysis.

Why Use a Protein Engineering Platform?

Traditional protein engineering often relies on generating and screening large mutation libraries, which can be expensive, time-consuming, and experimentally demanding.

An AI-driven protein engineering platform helps researchers:
  • Prioritize promising mutations
  • Reduce unnecessary experimental screening
  • Optimize multiple protein properties simultaneously
  • Accelerate Design-Build-Test-Learn (DBTL) cycles
  • Support data-driven engineering decisions
  • Improve research productivity
Rather than replacing laboratory work, the platform complements experimental workflows by helping focus resources on the most promising candidates.

Platform Capabilities

Neoncorte Bio's Protein Engineering Platform supports a broad range of computational workflows, including:
  • Protein sequence analysis
  • Structure-informed protein modeling
  • Protein language models (PLMs)
  • Zero-shot mutation prediction
  • Computational mutagenesis
  • Virtual Deep Mutational Scanning (DMS)
  • Protein fitness landscape prediction
  • Epistasis prediction
  • Higher-order mutation prediction
  • Active learning
  • Bayesian optimization
  • Smart library design
  • Multi-objective optimization
  • Design-Build-Test-Learn (DBTL) support
These capabilities can be integrated into existing protein engineering pipelines or used to support new R&D programs.

Protein Engineering Objectives

The platform helps prioritize variants for optimization of:
  • Catalytic activity
  • Catalytic efficiency
  • Protein stability
  • Thermostability
  • Melting temperature (Tm)
  • Binding affinity
  • Protein developability
  • Manufacturability
  • Expression yield
  • Aggregation resistance
  • Protein solubility
  • pH stability
  • Solvent tolerance
  • Oxidative stability
  • Freeze-thaw stability
  • Cofactor specificity
  • Substrate specificity
  • Enantioselectivity
  • Multi-parameter optimization
Optimization strategies are customized according to the biological target and project objectives.

Core Platform Modules

  • Protein Engineering Platform
    AI-Guided Mutation Prioritization
    Identify mutations predicted to improve target protein properties before laboratory validation.
  • Protein Engineering Platform
    Computational Mutagenesis
    Estimate the potential effects of amino acid substitutions using AI-assisted computational models.
  • Protein Engineering Platform
    Virtual Deep Mutational Scanning
    Evaluate extensive mutational landscapes computationally to identify high-priority variants.
  • Protein Engineering Platform
    Protein Fitness Landscape Analysis
    Explore sequence-function relationships and identify favorable evolutionary trajectories.
  • Protein Engineering Platform
    Smart Library Design
    Create focused mutation libraries that maximize information while minimizing screening effort.
  • Protein Engineering Platform
    Multi-Parameter Optimization
    Simultaneously optimize activity, stability, manufacturability, expression, and other engineering objectives.

Industries We Support

Protein Engineering Platform
  • Enzyme Engineering

    Optimize industrial enzymes for catalytic performance, stability, and manufacturing.
  • Synthetic Biology

    Optimize proteins for metabolic engineering and engineered biological systems.
  • Therapeutic Proteins

    Support engineering of biologics with improved stability and manufacturability.
  • Diagnostics

    Develop proteins with enhanced stability and analytical performance.
  • Industrial Biotechnology

    Engineer proteins for sustainable manufacturing, biocatalysis, and specialty chemicals.
Protein Engineering Platform

Design-Build-Test-Learn (DBTL) Collaboration

The Protein Engineering Platform supports every phase of iterative protein optimization.
Design
Analyze protein sequences, structures, and engineering objectives.
Build
Prioritize mutations and focused libraries for experimental evaluation.
Test
Incorporate laboratory results into predictive models.
Learn
Continuously refine computational models using newly generated experimental data.

This iterative workflow helps improve engineering efficiency throughout the project lifecycle.
protein engineering platform dbtl

What Neoncorte Bio Delivers

  • AI-guided protein engineering
  • Computational protein engineering
  • Protein sequence analysis
  • Protein language model integration
  • Computational mutagenesis
  • Virtual Deep Mutational Scanning
  • Protein fitness landscape prediction
  • Epistasis prediction
  • Active learning
  • Bayesian optimization
  • Smart library design
  • Multi-parameter optimization
  • Flexible integration with existing R&D workflows

Who Uses the Platform?

The Protein Engineering Platform is designed for:
  • Biotechnology companies
  • Pharmaceutical companies
  • Industrial enzyme manufacturers
  • Antibody developers
  • Synthetic biology organizations
  • CROs and CDMOs
  • Diagnostics developers
  • Academic research institutions
Frequently Asked Questions (FAQs)
Neoncorte Bio
Where AI Meets Biotechnology
Neoncorte Bio is at the forefront of the convergence between artificial intelligence and enzyme engineering. Our team comprises experts in computational biology, bioinformatics, and machine learning, all driven by a mission to accelerate innovation in enzyme design. By leveraging our advanced AI models, we provide unparalleled solutions that enhance efficiency, reduce costs, and push the boundaries of what's possible in enzyme engineering
Proud Member of Leading Global AI Programs
Neoncorte Bio is part of the NVIDIA Inception and Nebius for Startups programs — two of the world’s leading ecosystems for high-performance AI innovation. These partnerships strengthen our ability to deliver next-generation AI-driven protein, enzyme, and aptamer engineering.
  • NVIDIA Inception Neoncorte Bio AI life sciences company
    As a member of NVIDIA Inception, Neoncorte Bio gains access to cutting-edge GPU technologies, expert guidance, and a global AI ecosystem that supports companies from prototype to production. The program empowers us to explore new AI opportunities and build high-performance biological design pipelines powered by NVIDIA’s world-class platform.
  • Nebius AI life sciences Neoncorte Bio
    Through Nebius for Startups, we gain access to high-performance compute infrastructure optimized for large-scale AI workloads, along with hands-on technical guidance and a strong community of innovative AI companies. Nebius enables us to train and deploy complex biological models more efficiently — accelerating enzyme, protein, and aptamer design while supporting rapid scaling of our R&D pipelines.
Publications
Scientific Publication of Neoncorte Bio Team
  • Modification of natural enzymes to introduce new properties and enhance existing ones is a central challenge in bioengineering. This study is focused on the development of Taq polymerase mutants that show enhanced reverse transcriptase (RTase) activity while retaining other desirable properties such as fidelity, 5′-3′ exonuclease activity, effective deoxyuracil incorporation, and tolerance to locked nucleic acid (LNA)-containing substrates.
  • The transcriptomic data are being frequently used in the research of biomarker genes of different diseases and biological states. The most common tasks there are the data harmonization and treatment outcome prediction. Both of them can be addressed via the style transfer approach. Either technical factors or any biological details about the samples which we would like to control (gender, biological state, treatment, etc.) can be used as style components.
  • List of all Neoncorte Bio publications dedicated to Molecular Biology, Biotechnology, Artificial Intelligence and Artificial Neural Networks, published mostly by Nikolay Russkikh, CEO of Neoncorte Bio

Our Expertise in Action
With extensive experience in AI applications and software engineering tailored to the life sciences, we specialize in solving complex challenges and delivering innovative solutions for our customers. Our work demonstrates a deep understanding of cutting-edge technologies and their application in the real world.
Here are examples of the types of projects we have successfully delivered:
  • Automated NGS Data Analysis:
    Designed a production-grade solution for the automated processing, annotation, and analysis of Next-Generation Sequencing (NGS) data.
  • Single-Cell Data Integration:
    Built state-of-the-art tools for integrating multimodal single-cell data, achieving recognition for technical excellence.
  • Metagenomic Classification Algorithms:
    Developed advanced methods for classifying sequencing reads in metagenomics research.
  • High-Throughput Image Processing Pipelines:
    Engineered an efficient pipeline to process millions of sequencing images with exceptional accuracy.
  • Cell Counting via AI:
    Created a computer vision solution for precise cell counting in microphotography images, streamlining data analysis.
Get in touch with our team
Phone: +1-503-754-3958
Email: contact@neoncorte.com